European Court Sentences Sick Baby To Death

3 Min Read

A European Human Rights Court has given its final verdict on a case of human rights that will compel a couple to allow their sick baby to die.

The parents of the baby, Chris Gard and Connie Yates have been in a long legal battle to save their baby who is suffering from a serious genetic illness.

According to reports, the baby is currently on life support while treatment options were being considered.

At 8 weeks old, Charlie was diagnosed with mitochondrial DNA depletion syndrome and is considered to be only one of 16 babies worldwide with this disease.

His condition is progressive, currently incurable and eventually fatal.

Charlie’s parents prayed the court to determine if they, as parents, have the right to continue to provide medical treatments for their son or if he should be allowed to die.

The parents of the 10-months old baby wants the court to let them use a potentially life-saving drug from the U.S. on their son.

They believed that the drug (which is still experimental), would help their son’s genetic condition rather than allow him to die as doctors have recommended.

However a June 27 ruling of the court held that the application by the parents was ‘inadmissible’.

The court said that the baby was being exposed to continued pain, suffering and distress in pursuit of treatments that were unsure.

It added that any additional treatment would continue to cause harm to the baby stressing that its ruling is “Final”.

“The EHRC also removed the interim measure to keep Charlie’s life support in place.

Meanwhile, Charlie’s parents have so far raised over £1.3 million through a GoFundMe account for his treatment.

With the ruling of the court, the parents are unsure what they want to do with the money.

They plan to donate some to the U.S. hospital willing to treat Charlie, while the rest will be put into a charity for other children with similar mitochondrial conditions “so that nobody else ever has to go through what we have.”

Share this Article
Leave a comment

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.